Epi-off corneal collagen cross-linking (CXL) treatment treats progressive keratoconus and ectasia that develops after refractive surgery. The procedure received FDA approval in 2016. Dr. Greenstein and his colleagues conducted a study to determine how well the procedure faired over the years. The study concluded that the treatment appears to remain stable for the majority of […]
Read More